You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 8, August 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevalence and Characteristics of Anti—Single-Stranded DNA Antibodies in Localized Scleroderma

Comparison With Systemic Lupus Erythematosus

Amelia Ruffatti, MD; Andrea Peserico, MD; Riccardo Rondinone, MD; Antonia Calligaro, MD; Teresa Del Ross, MD; Anna Ghirardello; Maurizio Germino, MD; Silvano Todesco, MD

Arch Dermatol. 1991;127(8):1180-1183.


Abstract

• Prevalence, levels, and immunoglobulin classes of anti— single-stranded DNA antibodies were determined by an enzyme-linked immunosorbent assay in 52 patients with localized scleroderma (33 with morphea, four with generalized morphea, and 15 with linear scleroderma), in 60 healthy controls, and, for comparison, in 31 patients with systemic lupus erythematosus. Localized scleroderma revealed a significant prevalence of anti—single-stranded DNA antibodies, mainly characterized by high levels and IgM and IgA isotypes. Comparison of antibody characteristics in different clinical forms of localized scleroderma showed some significant differences (levels and immunoglobulin isotypes). Comparison with systemic lupus erythematosus showed that frequency, high levels, and IgG isotype of anti—single-stranded DNA antibodies significantly prevailed in systemic lupus erythematosus, while the IgM isotype significantly prevailed in localized scleroderma. However, generalized morphea and linear scleroderma did not significantly differ from systemic lupus erythematosus as regards antibody frequency and prevalence of high antibody levels.

(Arch Dermatol. 1991;127:1180-1183)



Author Affiliations

From the Division of Rheumatology, Institute of Internal Medicine (Drs Ruffatti, Calligaro, Del Ross, and Todesco, and Ms Ghirardello), and the Department of Dermatology (Drs Peserico, Rondinone, and Germino), University of Padova (Italy).


Footnotes

Accepted for publication January 31, 1991.

Reprint requests to Cattedra di Reumatologia, Istituto di Medicina Interna, Via Giustiniani 2, 35128 Padova, Italy (Dr Todesco).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Localized scleroderma is an autoimmune disorder
Takehara and Sato
Rheumatology (Oxford) 2005;44:274-279.
ABSTRACT | FULL TEXT  

Evidence of autoantibodies to cell membrane associated DNA (cultured lymphocytes): a new specific marker for rapid identification of systemic lupus erythematosus
Servais et al.
Ann Rheum Dis 1998;57:606-613.
ABSTRACT | FULL TEXT  

Absence of Anti-Single-Stranded DNA Antibodies in Vulvar Lichen Sclerosus et Atrophicus
Hacker et al.
Arch Dermatol 1994;130:1454-1455.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.